Skip to content
Disclosery

13F-HR filed by DAFNA Capital Management LLC

DAFNA Capital Management LLC filed this 13F-HR for the quarter ended 2024-03-31, filed 2024-05-15, with 72 holding rows worth $439,278,544.

Accession
0001389932-24-000012
Filer
CIK 1389933
Filed
2024-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2024

A holdings report, 72 entries on the cover page, a total value of $439,278,544 stated on the cover page (in dollars after the unit check, H1), rows summing to $439,278,544 with VALUE read as dollars as filed, 13F file number 028-12327. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SPDR SER TR78464A870S&P BIOTECH431,215$40,917,991dollars as filed
STEREOTAXIS INC85916J409COMMON STOCK13,680,554$35,706,246dollars as filed
CYTOKINETICS INC23282W605COM NEW398,100$27,910,791dollars as filed
IDEAYA BIOSCIENCES INC COM45166A102Stock446,341$19,585,443dollars as filed
MERUS N VN5749R100COM378,995$17,066,145dollars as filed
REVOLUTION MEDICINES INC COM76155X100Stock511,894$16,498,344dollars as filed
VIKING THERAPEUTICS INC92686J106COM194,117$15,917,594dollars as filed
SYNDAX PHARMACEUTICALS INC87164F105COM659,574$15,697,861dollars as filed
ISHARES TR464287556ISHARES BIOTECH102,500$14,065,050dollars as filed
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR92,472$13,978,992dollars as filed
XENON PHARMACEUTICALS INC COM98420N105Stock273,739$11,784,464dollars as filed
Day One Biopharmaceuticals Inc23954D109Common Stock666,463$11,009,969dollars as filed
BLUEPRINT MEDICINES CORP09627Y109COM106,763$10,127,538dollars as filed
NEUROCRINE BIOSCIENCES INC64125C109COM71,615$9,877,141dollars as filed
KALVISTA PHARMACEUTICALS INC483497103COM806,973$9,570,700dollars as filed
TANDEM DIABETES CARE INC875372203COM NEW258,208$9,143,145dollars as filed
DEXCOM INC COM252131107Stock65,552$9,092,062dollars as filed
KURA ONCOLOGY INC COM50127T109Stock412,663$8,802,102dollars as filed
ATRICURE INC04963C209COM271,029$8,244,702dollars as filed
MORPHIC HLDG INC61775R105COM231,748$8,157,530dollars as filed
AXOGEN INC05463X106COM935,894$7,552,665dollars as filed
BIOHAVEN LTDG1110E107COM118,730$6,493,344dollars as filed
2SEVENTY BIO INC COMMON STOCK901384107Stock1,204,051$6,441,673dollars as filed
EDGEWISE THERAPEUTICS INC28036F105COM306,197$5,585,033dollars as filed
ALECTOR INC014442107COMMON STOCK912,928$5,495,827dollars as filed
CENTURY THERAPEUTICS INC15673T100COM1,307,407$5,464,961dollars as filed
LARIMAR THERAPEUTICS INC517125100COM656,373$4,981,871dollars as filed
Ascendis Pharma A/S04351PAD3Convertible bond4,000,000$4,610,000dollars as filedprincipal
KEROS THERAPEUTICS INC COM492327101Stock67,754$4,485,315dollars as filed
ARCUS BIOSCIENCES INC03969F109COM231,717$4,374,817dollars as filed
LAKEFRONT BIOTHERAPEUTICS NV36315X101SPON ADR130,175$4,191,635dollars as filed
PERSPECTIVE THERAPEUTICS INC46489V104COM3,103,644$3,693,336dollars as filed
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock709,500$3,604,260dollars as filed
ASTRIA THERAPEUTICS INC COM04635X102Stock223,265$3,142,455dollars as filed
REGULUS THERAPEUTICS INC75915K309COM1,070,548$3,083,178dollars as filed
BICYCLE THERAPEUTICS PLC-ADR088786108SPONSORED ADS122,200$3,042,780dollars as filed
ACCURAY INC DEL004397105COM1,222,358$3,019,224dollars as filed
INSULET CORP COM45784P101Stock15,900$2,725,260dollars as filed
PROCEPT BIOROBOTICS CORP COM74276L105Stock54,995$2,717,853dollars as filed
MEDIWOUND LTDM68830112COMMON STOCK188,753$2,689,730dollars as filed
ARS PHARMACEUTICALS INC82835W108COM239,194$2,444,563dollars as filed
AQUESTIVE THERAPEUTICS INC COM03843E104Stock500,000$2,130,000dollars as filed
PROQR THERAPEUTICS NVN71542109SHS EURO905,582$2,073,692dollars as filed
COMPASS PATHWAYS PLC20451W101SPONSORED ADS243,210$2,023,507dollars as filed
LINEAGE CELL THERAPEUTICS IN53566P109COMMON STOCK1,366,308$2,022,136dollars as filed
STOKE THERAPEUTICS INC86150R107COM145,000$1,957,500dollars as filed
SUTRO BIOPHARMA INC869367102COM334,079$1,887,546dollars as filed
INOGEN INC45780L104COM208,790$1,684,935dollars as filed
GOSSAMER BIO INC COM38341P102Stock1,409,262$1,662,929dollars as filed
BRAINSWAY LTD10501L106CMN297,655$1,574,595dollars as filed
BIONTECH SE SPONSORED ADS09075V102ADR17,000$1,568,250dollars as filed
IMMATICS N.VN44445109SHS145,000$1,523,950dollars as filed
NEURONETICS INC64131A105COM313,717$1,493,293dollars as filed
ADICET BIO INC007002108COM600,000$1,410,000dollars as filed
AUTOLUS THERAPEUTICS PLC SPON05280R100COM216,667$1,382,335dollars as filed
ACELYRIN INC00445A100COM202,587$1,367,462dollars as filed
ITEOS THERAPEUTICS INC46565G104COM98,560$1,344,358dollars as filed
MINERALYS THERAPEUTICS INC603170101COM90,000$1,161,900dollars as filed
COMPUGEN LTDM25722105ORD430,202$1,109,921dollars as filed
IMMUNOVANT INC45258J102COM29,416$950,431dollars as filed
ACRIVON THERAPEUTICS INC004890109CMN131,351$939,160dollars as filed
APREA THERAPEUTICS INC03836J201COM NEW137,174$917,694dollars as filed
POLYPID LTDM8001Q126COM185,446$853,052dollars as filed
SYROS PHARMACEUTICALS INC87184Q206COM NEW135,850$726,798dollars as filed
ADAPTIMMUNE THERAPEUTICS PLC00653A107SPONDS ADR341,064$538,881dollars as filed
MASIMO CORP COM574795100Stock3,000$440,550dollars as filed
NEVRO CORP64157F103COM28,000$404,320dollars as filed
KARYOPHARM THERAPEUTICS INC48576U106COM192,678$290,944dollars as filed
VIGIL NEUROSCIENCE INC92673K108COM71,815$244,889dollars as filed
COMPASS THERAPEUTICS INC20454B104COM116,882$231,426dollars as filed
SPERO THERAPEUTICS INC84833T103COM125,000$215,000dollars as filed
ALTO NEUROSCIENCE INC COM SHS02157Q109Stock10,000$153,500dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001389932-24-000012this filing2024-05-15acceptance time not in the bulk data set